Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report

[1]  C. Leporini,et al.  Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases , 2013, Journal of pharmacology & pharmacotherapeutics.

[2]  P. Kuebler,et al.  Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach. , 2013, Investigative ophthalmology & visual science.

[3]  R. Kirchmair,et al.  Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema , 2013, British Journal of Ophthalmology.

[4]  Jesse J. Jung,et al.  Long-term follow-up of outer retinal tubulation documented by eye-tracked and en face spectral-domain optical coherence tomography. , 2012, Archives of ophthalmology.

[5]  José-Alain Sahel,et al.  En Face OCT Imaging for the Diagnosis of Outer Retinal Tubulations in Age-Related Macular Degeneration , 2012, Journal of ophthalmology.

[6]  R. Adelman,et al.  Intravitreal Ranibizumab for Treatment of Choroidal Neovascularization Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: Five-year Follow-up , 2012, Seminars in ophthalmology.

[7]  W. Amoaku,et al.  Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks , 2012, Eye.

[8]  P. Charbel Issa,et al.  Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. , 2011, American journal of ophthalmology.

[9]  H. Scholl,et al.  LONG-TERM EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS IN PSEUDOXANTHOMA ELASTICUM , 2011, Retina.

[10]  Glenn J Jaffe,et al.  Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.

[11]  H. Loi,et al.  Myositis Ossificans , 2011, The western journal of emergency medicine.

[12]  E. Souied,et al.  Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. , 2010, American journal of ophthalmology.

[13]  S. Sivaprasad,et al.  Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age-related macular degeneration , 2010, Eye.

[14]  H. Scholl,et al.  Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. , 2009, Survey of ophthalmology.

[15]  G. Kalantzis,et al.  Angioid streaks, clinical course, complications, and current therapeutic management , 2008, Therapeutics and clinical risk management.

[16]  Sumio Watanabe,et al.  Journal of Medical Case Reports , 2022 .